Application of frameless stereotactic aspiration in the treatment of hypertension cerebral hemorrhage / 解放军医学杂志

ABSTRACT

Objective To investigate the technical points and clinical outcomes of frameless stereotactic aspiration in treatment of patients with hypertension cerebral hemorrhage (HPCH). Methods The clinical data of 68 consecutive patients with HPCH, treated with frameless stereotactic aspiration from Jan. 2012 to Jun. 2014, were retrospectively analyzed, and compared to that of 45 patients treated in the meantime by frame-based stereotactic aspiration. The surgical results, procedure-related complications and clinical prognosis were evaluated. Results For the patients treated with frameless stereotactic aspiration, the median age was 53.3 years (range 36-80), the mean initial Glasgow coma scale score was over 5. Among them seven patients died within a month after operation 3 died of respiratory failure, 2 of cerebral edema and 2 of rehemorrhage. At the six-months followup, the good recovery rate (grade I-III of ADL) was 77.9%(53/68), better than that of patients treated with frame-based stereotactic aspiration (60.0%, P<0.05). Conclusion Frameless stereotactic aspiration for HPCH is easy to operate, minimal invasion and safe procedure with low mortality and rehemorrhage rate.